News
First Patient Enrolled in reMARQable Clinical Study Evaluating the Safety and Efficacy of Multi-Electrode nMARQ™ Pulmonary Vein Isolation System™ in the Treatment of Paroxysmal Atrial Fibrillation
May 9, 2013 9:49 am | by The Associated Press | CommentsDIAMOND BAR, Calif.--(BUSINESS WIRE)--May 9, 2013--Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, today announced the first patient has been enrolled in the reMARQable clinical study. ReMARQable will assess the safety and efficacy of the use of...
IMS Health Study Points to a Declining Cost Curve for U.S. Medicines in 2012
May 9, 2013 8:00 am | by The Associated Press | CommentsPARSIPPANY, N.J.--(BUSINESS WIRE)--May 9, 2013--Total spending on U.S. medicines fell 3.5 percent on a real per capita basis in 2012 and the use of healthcare services overall declined for the second consecutive year, according to a new study released today by the IMS Institute for Healthcare...
Wi2Wi is Awarded First Production Order from another Major Global Leader in Medical Devices
May 9, 2013 7:45 am | by The Associated Press | CommentsTORONTO--(BUSINESS WIRE)--May 9, 2013--Wi2Wi Corporation ("Wi2Wi" or the "Company") (TSX-V: YTY) is pleased to announce that a leading global pharmaceutical company with a substantial medical diagnostic division has placed its first production order for 10,000 units of Wi2Wi’s Single-Antenna...
UNT Professor’s Laser Technology Could Change the Way Surgeons Operate
May 8, 2013 1:51 pm | by University of North Texas | CommentsA University of North Texas professor has filed a patent on a new laser technology he and his research associate developed for cutting and shaping bone that causes minimal damage to the surrounding tissue and bones, could speed up surgery and recovery times, and even lessen the amount of blood lost during operations.
Varian Enables HIPAA Compliance and Optimizes Customer Service with the Axeda Machine Cloud
May 8, 2013 1:49 pm | by The Associated Press | CommentsAxeda Corporation, the leading provider of cloud-based service and software for managing connected products and delivering machine-to-machine (M2M) applications, today announced that Varian Medical Systems, a leading manufacturer of medical devices and software for treating cancer and other...
Study Shows GenomeDx's Decipher™ Test Effectively Predicts Rapid Metastatic Prostate Cancer
May 8, 2013 1:30 pm | by PR Newswire | CommentsSAN DIEGO, May 8, 2013 /PRNewswire/ -- GenomeDx Biosciences today announced that data presented by Johns Hopkins University School of Medicine researchers at the 2013 Annual Meeting for the American Urological Association demonstrated that Decipher™, a transformative genomic test...
Improved Material for "Laser Welding" of Tissue in Intestinal Surgery
May 8, 2013 1:08 pm | by American Chemical Society | CommentsA new "solder" for laser welding of tissue during surgical operations has the potential to produce stronger seals and expand use of this alternative to conventional sutures and stapling in intestinal surgery, scientists are reporting. Their study, which involves use of a gold-based solder, or sealing material, appears in the journal ACS Nano.
New Technique Can Help Nanoparticles Deliver Drug Treatments
May 8, 2013 11:13 am | by Wayne State University - Office of the Vice President for Research | CommentsA Wayne State University researcher has successfully tested a technique that can lead to more effective use of nanoparticles as a drug delivery system. Joshua Reineke, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences, examined how a biodegradable polymer particle called polylactic-co-glycolic acid breaks down in live tissue.
Bacteria Adapt and Evade Nanosilver’s Sting
May 8, 2013 11:11 am | by UNSW | CommentsResearchers from UNSW have cautioned that more work is needed to understand how micro-organisms respond to the disinfecting properties of silver nano-particles, increasingly used in consumer goods, and for medical and environmental applications.
Exosome Diagnostics Presents Data Demonstrating Utility of Urine Exosome Technology to Predict Prostate Biopsy Outcome at American Urological Association Annual Meeting
May 8, 2013 11:00 am | by PR Newswire | CommentsNEW YORK, May 8, 2013 /PRNewswire/ -- Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and clinical diagnostics, today announced the presentation of data at the American Urological Association Annual...
Thoracic Endografts Used Successfully to Remove Tumors Invading the Aorta
May 8, 2013 10:43 am | by American Association for Thoracic Surgery | CommentsSome chest tumors may invade one of the great vessels of the body, the aorta. Surgical removal of these tumors is very challenging and necessitates the support of a heart-lung machine. Therefore, there is an increased risk of complication and death. In a small series of patients, placing a stent within the aorta facilitated the subsequent removal of tumor and eliminated the need for heart-lung bypass.
Biosensor that Detects Antibiotic Resistance Brings Us One Step Closer to Fighting Superbugs
May 8, 2013 10:40 am | by The Journal of Visualized Experiments | CommentsOn May 8th, JoVE published research that demonstrates how a biosensor can detect antibiotic resistance in bacteria. This new technology is a preliminary step in identifying and fighting superbugs, a major public health concern that has led to more deaths than AIDS in the United States in recent years.
Electric Nose Can Smell
May 8, 2013 10:31 am | by FECYT - Spanish Foundation for Science and Technology | CommentsSwedish and Spanish engineers have created a system of sensors that detects fruit odours more effectively than the human sense of smell. For now, the device can distinguish between the odorous compounds emitted by pears and apples. The electronic nose has 32 sensors to identify smells.
New Prostate Cancer Test Improves Risk Assessment
May 8, 2013 10:26 am | by University of California - San Francisco | CommentsA new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study. The test, which improves risk assessment when patients are first diagnosed, can also aid in determining which men are suitable for active surveillance.
IonMed Announces Successful Completion of the First European Cold Plasma Clinical Study for Closure of Surgical Wounds
May 8, 2013 9:01 am | by The Associated Press | CommentsResults from a 16 patient study led by Prof. Abrahamyan at the Republican Institute of Reproductive Health, Perinatology, Obstetrics and Gynecology in Yerevan, Armenia demonstrate the safety and effectiveness of IonMed's BioWeld1TM cold plasma system. BioWeld1 is the first cold-plasma...
